HomepageEarnings Events Newsdesk 27 minutes ago Merck & Co., Inc. (MRK) Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) Merck & Co., Inc. (NYSE: MRK) FY 2026 Other Release Taylor Morrison Home Corp (TMHC) Q1 2026 Earnings Announcement » « Merck & Co., Inc. (MRK) Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) Newsdesk:
